12/12
07:13 am
zntl
Zentalis Pharmaceuticals Announces Key Management Appointments [Yahoo! Finance]
Medium
Report
Zentalis Pharmaceuticals Announces Key Management Appointments [Yahoo! Finance]
12/12
07:00 am
zntl
Zentalis Pharmaceuticals Announces Key Management Appointments
High
Report
Zentalis Pharmaceuticals Announces Key Management Appointments
12/10
02:32 pm
zntl
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
12/2
04:35 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/21
01:14 pm
zntl
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
11/21
08:08 am
zntl
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors [Yahoo! Finance]
Low
Report
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors [Yahoo! Finance]
11/15
02:07 pm
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Guggenheim from $12.00 to $8.00. They now have a "buy" rating on the stock.
Low
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Guggenheim from $12.00 to $8.00. They now have a "buy" rating on the stock.
11/15
08:03 am
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
High
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
11/13
08:00 am
zntl
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
Low
Report
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
11/1
07:04 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/15
08:47 am
zntl
Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News [Yahoo! Finance]
Low
Report
Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News [Yahoo! Finance]